Investment Team

Benzion Amoyav

Analyst

Benzion joined Sphera in 2024 as a Scientific Analyst at the Sphera Healthcare Fund & Biotech Fund, where he leverages his scientific and pharmaceutical expertise to support the biotech and healthcare fund team’s decision-making. He focuses on analyzing corporate development and conducting market research of public companies from early to late clinical stages.
During his PhD, Benzion conducted innovative research combining cutting-edge technologies, which resulted in several publications in top-ranking journals.
Benzion holds an MBA with a specialization in Marketing, both degrees earned from The Hebrew University of Jerusalem.

Skip to content